Skip to search formSkip to main contentSkip to account menu

Tuberculosis, Multidrug-Resistant

Known as: MDR-TB, multidrug resistant tuberculosis, Multidrug-Resistant TB 
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance… 
National Institutes of Health

Related topics

Related topics

13 relations
Antitubercular AgentsDrug Resistance, BacterialDrug Resistance, MicrobialDrug Resistance, Multiple, Bacterial

Broader (1)

Tuberculosis, Drug-Resistant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy
ABSTRACT In tuberculosis treatment, susceptibility is defined by a critical concentration of 1.0 mg/liter for rifampin and 0.2 or… 
Highly Cited
2013
Highly Cited
2013
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets.
2010
2010
Highly Effective , and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Rationale: Based on expert opinion, the global guidelines for management of multidrug-resistant tuberculosis impose lengthy and… 
2006
2006
Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells.
The hydroxystilbene trans-3,5,3',4'-tetrahydroxystilbene (piceatannol) (1), isolated from the methanol extract of Euphorbia… 
Review
2003
Review
2003
Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
OBJECTIVE To review the incidence and management of peripheral neuropathy in patients receiving therapy for MDR-TB. METHODS A… 
1997
1997
Rapid detection of multidrug-resistant tuberculosis.
Transmission of multidrug-resistant strains of Mycobacterium tuberculosis (MDR-TB) presents a serious problem for infection… 
Review
1997
Review
1997
A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
BACKGROUND A 1991 survey showed high levels of drug resistance among tuberculosis patients in New York, NY. As a result, the… 
1995
1995
Circumvention of P‐glycoprotein‐mediated drug resistance in human leukaemic cells by non‐immunosuppressive cyclosporin D analogue, SDZ PSC 833
Summary. Cyclosporin A (CSA) exhibits greater multidrug resistance (MDR) modulating activity in vitro than other MDR modulators… 
1991
1991
Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro.
Review
1990
Review
1990
Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)